Showing: 314 results
Clinical Trial Research
Investigator Initiated Trials - Sponsored Trials Arjo supports clinical trial research related to our products. Read all about our requirements for sponsor support or funding for clinical trials here.
In bed
Early mobilisation in bed | Arjo Mobilisation in bed. Methods to support patient rehabilitation and recovery through regular repositioning, progressive verticalisation and upright positioning. Advanced support surfaces and versatile bed frame
Clinical evidence on Early Mobility in the ICU
Clinical evidence survey on Early Mobility in the ICU | Arjo Early mobilisation has been shown to be both safe and feasible for patients admitted to critical care. Download our clinical evidence summary.
Capital Market Day 2019
Capital Market Day 2019 Arjo held its first Capital Markets day on March 12 2019, attended by analysts, institutional investors and the media. The keynote speakers at the Capital Markets Day were: Joacim Lindoff, President & CEO Jonas Lindqvist ... Anne Sigouin, President Sales & Service North America The presentations can be viewed in the following link: https://www.arjo.com/int/about-us/investors/reports--presentations/2019/
Annual General Meeting 2019
At the Annual General Meeting of Arjo AB held on 7 May 2019, the following was resolved. Johan Malmquist (Chairman), Carl Bennet, Eva Elmstedt, Ulf Grunander, Carola Lemne and Joacim Lindoff were re-elected as members of the Board. Dan Frohm
Walking
Walking rehabilitation - Early Mobility | Arjo Walking rehabilitation solutions. For patients sitting out on a daily basis on multiple occasions. To create more active exercise, standing and ambulation. When stepping or walking practice is required
Sitting
Sitting - Early Mobility | Arjo Sitting on edge of bed. Solutions to facilitate care and rehabilitation. Sitting facilitate good eye contact and personal interaction. For high-quality care. The Sara Combilizer enables patients to be placed into
Article of association
Articles of Association was adopted by an Extraordinary General Meeting on September 29, 2017. The name of the company is Arjo AB (publ). The object of the company’s operations shall be to, directly or indirectly through subsidiaries, engage in
Fact sheet
At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics
Auditors
Öhrlings PricewaterhouseCoopers AB is Arjo’s auditor since the company’s formation. Magnus Willfors is since August 16, 2017 auditor-in-charge. Magnus Willfors is an authorized public accountant and a member of FAR, the professional institute
Interim Report January-June 2019
Interim Report January-June 2019 Arjo's interim report for January-June 2019 will be published on July 18, 2019. We invite fund managers, analysts and the media to participate in the conference call. Please see details below to join the conference